264 related articles for article (PubMed ID: 27905004)
41. PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study.
Sah AK; Suresh PK; Verma VK
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-9. PubMed ID: 27389068
[TBL] [Abstract][Full Text] [Related]
42. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
Nagai N
Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
[TBL] [Abstract][Full Text] [Related]
43. Octa-arginine modified lipid emulsions as a potential ocular delivery system for disulfiram: A study of the corneal permeation, transcorneal mechanism and anti-cataract effect.
Liu C; Lan Q; He W; Nie C; Zhang C; Xu T; Jiang T; Wang S
Colloids Surf B Biointerfaces; 2017 Dec; 160():305-314. PubMed ID: 28950195
[TBL] [Abstract][Full Text] [Related]
44. Preparation and study of two kinds of ophthalmic nano-preparations of everolimus.
Tang Z; Yin L; Zhang Y; Yu W; Wang Q; Zhan Z
Drug Deliv; 2019 Dec; 26(1):1235-1242. PubMed ID: 31752553
[No Abstract] [Full Text] [Related]
45. Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide.
Quinteros DA; Ferreira LM; Schaffazick SR; Palma SD; Allemandi DA; Cruz L
J Pharm Sci; 2016 Oct; 105(10):3183-3190. PubMed ID: 27519647
[TBL] [Abstract][Full Text] [Related]
46. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
Afouna MI; Khedr A; Abdel-Naim AB; Al-Marzoqi A
J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
[TBL] [Abstract][Full Text] [Related]
47. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
[TBL] [Abstract][Full Text] [Related]
48. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
49. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
50. Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation.
Hou Y; Zhang F; Lan J; Sun F; Li J; Li M; Song K; Wu X
Drug Deliv; 2019 Dec; 26(1):158-167. PubMed ID: 30822157
[TBL] [Abstract][Full Text] [Related]
51. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
[TBL] [Abstract][Full Text] [Related]
52. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
[TBL] [Abstract][Full Text] [Related]
53. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.
Abdelbary A; Salem HF; Khallaf RA; Ali AM
Pharm Dev Technol; 2017 May; 22(3):409-417. PubMed ID: 27476543
[TBL] [Abstract][Full Text] [Related]
54. Preparation and Evaluation of Cubosomes/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis.
Gaballa SA; El Garhy OH; Moharram H; Abdelkader H
Pharm Res; 2020 Sep; 37(10):198. PubMed ID: 32968868
[TBL] [Abstract][Full Text] [Related]
55. Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability.
Varela-Garcia A; Concheiro A; Alvarez-Lorenzo C
Int J Pharm; 2018 Dec; 552(1-2):39-47. PubMed ID: 30253214
[TBL] [Abstract][Full Text] [Related]
56. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
[TBL] [Abstract][Full Text] [Related]
57. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
58. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045).
Cholkar K; Gilger BC; Mitra AK
Int J Pharm; 2016 Feb; 498(1-2):326-34. PubMed ID: 26706439
[TBL] [Abstract][Full Text] [Related]
59. Biodegradable Nanoparticles Based on Pseudo-Proteins Show Promise as Carriers for Ophthalmic Drug Delivery.
Zhang W; Kantaria T; Zhang Y; Kantaria T; Kobauri S; Tugushi D; Brücher V; Katsarava R; Eter N; Heiduschka P
J Ocul Pharmacol Ther; 2020; 36(6):421-432. PubMed ID: 32639222
[No Abstract] [Full Text] [Related]
60. Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.
Begum G; Leigh T; Courtie E; Moakes R; Butt G; Ahmed Z; Rauz S; Logan A; Blanch RJ
Sci Rep; 2020 Jul; 10(1):11754. PubMed ID: 32678110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
